Recently, we demonstrated that insulin reduces aortic waveform components (i.e., augmentation index corrected to the HR of 75 beats/min [AIx75], augmentation pressure [AP], forward wave component [Pf]; backward wave component [Pb]) and increases pulse pressure amplification (PPA) in people with MetS (Dotson et al., 2021). This evidence concerns the gene INS and metabolic syndrome.